Shukra Pharmaceuticals Limited has intimated the BSE Limited about a scheduled meeting of its Board of Directors. The meeting is set to be held on 11th August 2026 at the company's Registered Office located at 3rd Floor, "VEER HOUSE", Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
The primary agenda for the board meeting includes:
- Consideration and approval of the unaudited financial results for the quarter ended on 30th June 2026
- Review and approval of the Auditor's Limited Review Report accompanying the financial results
- Consideration of any other business matters with the permission of the Chairman
The financial impact of the quarterly results is pending board approval and has not been quantified in this disclosure.